GF-10053

N/A

Report date: 2025/06/23 17:27:10

Base Information

Drug NameGF-10053
Drug Alias NameGF-10053
ClassificationCell and gene therapy > Gene therapy
Mechanisms of ActionNAD-dependent protein deacetylase sirtuin-6 modulators
TargetsNAD-dependent protein deacetylase sirtuin-6
Therapy Area/IndicationsSarcopenia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesGenflow Biosciences PLC
China Registration ClassN/A

Develop Information

Active CompaniesGenflow Biosciences PLC
Inactive CompaniesN/A
Active IndicationsSarcopenia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A